Drug Information for ONDANSETRON Oral Solution, USP (Roxane Laboratories, Inc): INDICATIONS AND USAGE

Ads
    • Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin =50 mg/m2.
    • Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
    • Prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen.
    • Prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided postoperatively, Ondansetron Oral Solution, USP is recommended even where the incidence of postoperative nausea and/or vomiting is low.
  • Drug Information Provided by National Library of Medicine (NLM).
Ads